Med. praxi. 2014;11(3):106-108

Chronic kidney disease - role of nephrologist and general practitioner

prof.MUDr.Romana Ryšavá, CSc.
Klinika nefrologie, Univerzita Karlova v Praze, 1. lékařská fakulta a VFN, Praha

Chronic kidney disease affects nearly one tenth of the population and is becoming not only a medical, but also socioeconomic problem.

The best measure taken in order to slow down the epidemic of development of advanced disease stages is the implementation of screening

programmes to search for patients with a pre-existing renal injury or to identify those who have risk factors for its development (e.g. hypertension,

cardiovascular disease, diabetes mellitus or other metabolic disorders, risky medications etc.). New recommendations for assessment

and treatment of chronic kidney disease focus not only on the assessment of renal function by means of glomerular filtration rate and the

level of albuminuria, but emphasis is also placed on determining structural abnormalities in the renal parenchyma and identifying the cause

of kidney disease. Based on meta-analyses of large trials, a scheme for determining the risk of progression of chronic kidney disease has

been devised that recommends both the frequency of evaluations of renal parameters and the appropriateness of being followed up by a

nephrologist in individual patient categories. Groups of patients with a low risk of progression can be followed up by general practitioners

and in a longer time interval; patients with the highest risk should be followed up at least four times a year by a specialist, a nephrologist.

Keywords: chronic kidney disease, albuminuria, glomerular filtration rate

Published: May 15, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ryšavá R. Chronic kidney disease - role of nephrologist and general practitioner. Med. praxi. 2014;11(3):106-108.
Download citation

References

  1. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1.
  2. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kideny Int Supplements 2013; 3: 1-150.
  3. Rychlík I, Nehézová K. Epidemiologie chronického onemocnění ledvin. Pokroky v oboru nefrologie 2009; 3(1): 4-10.
  4. Tesař V. Renální riziko, koncept a kalkulace individuálního rizika. Pokroky v oboru nefrologie 2009; 3(1): 11-20.
  5. Doporučení České nefrologické společnosti a České společnosti klinické biochemie ČLS JEP k vyšetření glomerulární filtrace. Aktuality v nefrologii 2009; 15: 129-139.
  6. Lamb EJ, MacKenzie F, Stevens PE. How should proteinuria be detected and measured? Ann Clin Biochem 2009; 46: 205-217. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.